{ "labelLang" : "hun", "responseDate" : "2024-03-28 11:59", "content" : { "otype" : "JournalArticle", "mtid" : 25176443, "status" : "APPROVED", "published" : true, "comment" : "Megjegyzés-23242817\nN1 : Chemicals/CASaryldialkylphosphatase, 117698-12-1; diazoxon, 962-58-3; lipid, 66455-18-3; paraoxon, 311-45-5; phenylacetic acid, 103-82-2; Apolipoproteins; Aryldialkylphosphatase, EC 3.1.8.1; diazoxon, 962-58-3; Lipids; Lipoproteins; Organophosphorus Compounds; Paraoxon, 311-45-5; Phenylacetates; phenylacetic acid, 103-82-2; PON1 protein, human, EC 3.1.8.1", "unhandledTickets" : 0, "oldTimestamp" : "2017-10-27T19:25:29.000+0000", "deleted" : false, "oldId" : 15176443, "lastRefresh" : "2021-11-18T10:27:27.948+0000", "lastModified" : "2021-11-18T10:26:17.332+0000", "created" : "2015-11-23T15:56:56.000+0000", "creator" : { "otype" : "Author", "mtid" : 10003196, "link" : "/api/author/10003196", "label" : "Kovács Péter (Klinikai farmakológia)", "familyName" : "Kovács", "givenName" : "Péter", "published" : true, "oldId" : 10003196, "snippet" : true }, "lastDuplumOK" : "2021-11-18T10:26:17.674+0000", "lastDuplumSearch" : "2021-11-18T10:26:17.674+0000", "core" : false, "citation" : true, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 24, "link" : "/api/publicationtype/24", "label" : "Folyóiratcikk", "code" : 24, "otypeName" : "JournalArticle", "listPosition" : 1, "published" : true, "oldId" : 24, "snippet" : true }, "subType" : { "otype" : "SubType", "mtid" : 10000059, "link" : "/api/subtype/10000059", "label" : "Szakcikk (Folyóiratcikk)", "name" : "Szakcikk", "nameEng" : "Article", "docType" : { "otype" : "PublicationType", "mtid" : 24, "link" : "/api/publicationtype/24", "label" : "Folyóiratcikk", "code" : 24, "otypeName" : "JournalArticle", "listPosition" : 1, "published" : true, "oldId" : 24, "snippet" : true }, "listPosition" : 101, "published" : true, "oldId" : 10000059, "snippet" : true }, "category" : { "otype" : "Category", "mtid" : 1, "link" : "/api/category/1", "label" : "Tudományos", "published" : true, "oldId" : 1, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10002, "link" : "/api/language/10002", "label" : "Angol", "name" : "Angol", "nameEng" : "English", "published" : true, "oldId" : 2, "snippet" : true } ], "firstAuthor" : "Phuntuwate, W", "authorships" : [ { "otype" : "PersonAuthorship", "mtid" : 43000511, "link" : "/api/authorship/43000511", "label" : "Phuntuwate, W", "listPosition" : 1, "share" : 0.0, "first" : true, "last" : false, "familyName" : "Phuntuwate", "givenName" : "W", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 74623433, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 43000512, "link" : "/api/authorship/43000512", "label" : "Suthisisang, C", "listPosition" : 2, "share" : 0.0, "first" : false, "last" : false, "familyName" : "Suthisisang", "givenName" : "C", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 74623432, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 43000513, "link" : "/api/authorship/43000513", "label" : "Koanantakul, B", "listPosition" : 3, "share" : 0.0, "first" : false, "last" : false, "familyName" : "Koanantakul", "givenName" : "B", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 74623431, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 43000514, "link" : "/api/authorship/43000514", "label" : "Mackness, MI", "listPosition" : 4, "share" : 0.0, "first" : false, "last" : false, "familyName" : "Mackness", "givenName" : "MI", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 74623430, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 43000515, "link" : "/api/authorship/43000515", "label" : "Mackness, B", "listPosition" : 5, "share" : 0.0, "first" : false, "last" : true, "familyName" : "Mackness", "givenName" : "B", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 74623429, "snippet" : true } ], "title" : "Paraoxonase 1 status in the Thai population", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 9973162, "link" : "/api/publicationidentifier/9973162", "label" : "DOI: 10.1007/s10038-005-0255-7", "source" : { "otype" : "PlainSource", "mtid" : 6, "link" : "/api/publicationsource/6", "label" : "DOI", "type" : { "otype" : "PublicationSourceType", "mtid" : 10001, "link" : "/api/publicationsourcetype/10001", "label" : "DOI", "mayHaveOa" : true, "published" : true, "snippet" : true }, "name" : "DOI", "nameEng" : "DOI", "linkPattern" : "https://doi.org/@@@", "publiclyVisible" : true, "published" : true, "oldId" : 6, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "10.1007/s10038-005-0255-7", "realUrl" : "https://doi.org/10.1007%2Fs10038-005-0255-7", "published" : false, "oldId" : 10623930, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 20202163, "link" : "/api/publicationidentifier/20202163", "label" : "WoS: 000230593100004", "source" : { "otype" : "PlainSource", "mtid" : 1, "link" : "/api/publicationsource/1", "label" : "WoS", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "WoS", "nameEng" : "WoS", "linkPattern" : "http://gateway.isiknowledge.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=CustomerName&SrcApp=CustomerName&DestLinkType=FullRecord&KeyUT=@@@&DestApp=WOS", "publiclyVisible" : true, "published" : true, "oldId" : 1, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "000230593100004", "realUrl" : "http://gateway.isiknowledge.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=CustomerName&SrcApp=CustomerName&DestLinkType=FullRecord&KeyUT=000230593100004&DestApp=WOS", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 9973161, "link" : "/api/publicationidentifier/9973161", "label" : "Scopus: 23844551472", "source" : { "otype" : "PlainSource", "mtid" : 3, "link" : "/api/publicationsource/3", "label" : "Scopus", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "Scopus", "linkPattern" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@", "publiclyVisible" : true, "published" : true, "oldId" : 3, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "23844551472", "realUrl" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-23844551472", "published" : false, "oldId" : 10623929, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 14935819, "link" : "/api/publicationidentifier/14935819", "label" : "PubMed: 15924216", "source" : { "otype" : "PlainSource", "mtid" : 17, "link" : "/api/publicationsource/17", "label" : "PubMed", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "PubMed", "nameEng" : "PubMed", "linkPattern" : "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract", "publiclyVisible" : true, "published" : true, "oldId" : 17, "snippet" : true }, "validState" : "NO", "idValue" : "15924216", "realUrl" : "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15924216&dopt=Abstract", "published" : false, "oldId" : 3610478, "snippet" : true } ], "journal" : { "otype" : "Journal", "mtid" : 18584, "link" : "/api/journal/18584", "label" : "JOURNAL OF HUMAN GENETICS 1434-5161 1435-232X", "pIssn" : "1434-5161", "eIssn" : "1435-232X", "reviewType" : "REVIEWED", "noIF" : false, "sciIndexed" : true, "scopusIndexed" : true, "lang" : "FOREIGN", "hungarian" : false, "published" : true, "oldId" : 18584, "snippet" : true }, "volume" : "50", "issue" : "6", "firstPage" : "293", "lastPage" : "300", "firstPageOrInternalIdForSort" : "293", "pageLength" : 8, "publishedYear" : 2005, "digital" : null, "printed" : null, "sourceYear" : 2015, "packet" : "(Kovács Péter (Klinikai farmakológia); 2015.11.23. 16:56:26)", "foreignEdition" : true, "foreignLanguage" : true, "fullPublication" : true, "conferencePublication" : false, "nationalOrigin" : false, "missingAuthor" : false, "oaType" : "NONE", "oaCheckDate" : "2021-11-18", "oaFree" : false, "citationCount" : 0, "citationCountUnpublished" : 0, "citationCountWoOther" : 0, "independentCitCountWoOther" : 0, "doiCitationCount" : 0, "wosCitationCount" : 0, "scopusCitationCount" : 0, "independentCitationCount" : 0, "unhandledCitationCount" : 0, "citingPubCount" : 0, "independentCitingPubCount" : 0, "unhandledCitingPubCount" : 0, "citedPubCount" : 3, "citedCount" : 3, "ratings" : [ { "otype" : "SjrRating", "mtid" : 5968613, "link" : "/api/sjrrating/5968613", "label" : "sjr:Q2 (2005) Scopus - Genetics (clinical) JOURNAL OF HUMAN GENETICS 1434-5161 1435-232X", "listPos" : 33, "rankValue" : 0.49, "type" : "journal", "ratingType" : { "otype" : "RatingType", "mtid" : 10002, "link" : "/api/ratingtype/10002", "label" : "sjr", "code" : "sjr", "published" : true, "snippet" : true }, "subject" : { "otype" : "ClassificationExternal", "mtid" : 2716, "link" : "/api/classificationexternal/2716", "label" : "Scopus - Genetics (clinical)", "published" : true, "oldId" : 2716, "snippet" : true }, "ranking" : "Q2", "calculation" : "DIRECT", "published" : true, "oldId" : 5968613, "snippet" : true } ], "ratingsForSort" : "Q2", "referenceList" : "Abbott, C.A., Mackness, M.I., Kumar, S., Boulton, A.J., Durrington, P.N., Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins (1995) Arterioscler Thromb Vasc Biol, 15, pp. 1812-1818; \n\nAdkin, S., Gan, K.N., Mody, M., La Du, B.N., Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: Glutamine or arginine at position 191, for the respective a or B allozymes (1993) Am J Hum Genet, 52, pp. 598-608; \n\nAviram, M., Does paraoxonase play a role in susceptibility to cardiovascular disease (1999) Mol Med Today, 5, pp. 381-386; \n\nAviram, M., Billecke, S., Sorenson, R., Bisgaier, C., Newton, R., Rosenblat, M., Erogul, J., La Du, B.N., Paraoxonase active site required for protection against LDL oxidation involves its free sulhydryl group and is different from that required for its arylesterase/paraoxonase activities: Selective action of human paraoxonase allozymes Q and R (1998) Arterioscler Thromb Vasc Biol, 18, pp. 1617-1624; \n\nAviram, M., Rosenblat, M., Bisgaier, C.L., Newton, R.S., Primo-Parmo, S.L., La Du, B.N., Paraoxonase inhibits high density lipoprotein oxidation and preserves its functions: A possible peroxidative role for paraoxonase (1998) J Clin Invest, 101, pp. 1581-1590; \n\nAviram, M., Hardak, E., Vaya, J., Mahmood, S., Milo, S., Hoffman, A., Billicke, S., Rosenblat, M., Human serum paraoxonase (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions. PON1 esterase and peroxidase-like activities (2000) Circulation, 101, pp. 2510-2517; \n\nBalogh, Z., Fulop, P., Seres, I., Harangi, M., Katona, E., Kovacs, P., Kosztaczky, B., Paragh, G., Effect of simvastatin on serum paraoxonase activity (2001) Clin Drug Invest, 21, pp. 505-510; \n\nBlatter, M.C., James, R.W., Messmer, S., Barja, F., Pometta, D., Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein K-45 (1993) Eur J Biochem, 211, pp. 871-879; \n\nBlatter, M.C., James, R.W., Dussoix, P., Blanche, H., Passa, P., Froguel, P., Ruiz, J., Paraoxonase polymorphism Met-Leu 54 is associated with modified concentrations of the enzyme (1997) J Clin Invest, 99, pp. 62-66; \n\nBrophy, V.H., Jarvik, G.P., Richter, R.J., Rozek, L.S., Schellenberg, G.D., Furlong, C.E., Analysis of paraoxonase (PON1) L55M status requires both genotype and phenotype (2000) Pharmacogenetics, 10, pp. 453-460; \n\nBrophy, V.H., Jampsa, R.L., Clendenning, J.B., McKinstry, L.A., Jarvik, G.P., Furlong, C.E., Effects of 5′ regulatory region polymorphisms on paraoxonase-gene (PON1) expression (2001) Am J Hum Genet, 68, pp. 1428-1436; \n\nCao, H., Girard-Cloba, A., Serusclat, A., Bernard, S., Bondon, P., Piicard, S., Berthezene, F., Moulin, P., Lack of association between carotid intima-media thickness and paraoxonase polymorphisms in non-insulin dependent diabetes mellitus (1998) Atherosclerosis, 138, pp. 361-366; \n\nCao, H., Girard-Globa, A., Berthezene, F., Moulin, P., Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q → R genetic polymorphism (1999) J Lipid Res, 40, pp. 133-139; \n\nDatoine, T.F., Debord, J., Charmes, J.P., Decrease of serum paraoxonase activity in chronic renal failure (1998) J Am Soc Nephrol, 9, pp. 2082-2088; \n\nDavies, H.G., Richter, R.J., Keifer, M., Broomfield, C.A., Sowalla, J., Furlong, C.E., The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin (1996) Nat Genet, 14, pp. 334-336; \n\nFerre, N., Tous, M., Paul, A., Zamora, A., Vendrell, J.J., Bardaji, A., Camps, J., Joven, J., Paraoxonase Gln-Arg (192) and Leu-Met (55) gene polymorphisms and enzyme activity in a population with a low rate of coronary heart disease (2002) Clin Biochem, 35, pp. 197-203; \n\nFerretti, G., Bacchetti, T., Maratti, E., Curatola, G., Effect of homocysteinylation on human high-density lipoproteins: A correlation with paraoxonase activity (2003) Metabolism, 52, pp. 146-151; \n\nHegele, R.A., Brunt, J.H., Connelly, P.W., A polymorphism of the paraoxonase gene associated with variation in plasma lipoproteins in a genetic isolate (1995) Arterioscler Thromb Vasc Biol, 15, pp. 89-95; \n\nHerrmann, S.M., Blanc, H., Poirier, O., Arveiler, D., Luc, G., Evans, A., Marques-Vidal, P., Cambien, F., The Gln/Arg polymorphism of human paraoxonase (PON192) is not related to myocardial infarction in the ECTIM study (1996) Atherosclerosis, 126, pp. 299-303; \n\nHumbert, R., Alder, D.A., Disteche, C.M., Hassett, C., Omiecinski, C.J., Furlong, C.E., The molecular basis of the human serum paraoxonase activity polymorphism (1993) Nat Genet, 3, pp. 73-76; \n\nIkeda, Y., Suehiro, T., Inoue, M., Nakauchi, Y., Morita, T., Arii, K., Ito, H., Hashimoto, K., Serum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin dependent diabetes mellitus (1998) Metabolism, 47, pp. 598-602; \n\nImai, Y., Morita, H., Kurihara, H., Sugiyama, T., Kato, N., Ebihara, A., Hamada, C., Yazaki, Y., Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases (2000) Atherosclerosis, 149, pp. 435-442; \n\nJarvik, G.P., Rozek, L.S., Brophy, V.H., Hatsukami, T.S., Richter, R.J., Schellenberg, G.D., Furlong, C.E., Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1192 or PON155 genotype (2000) Arterioscler Thromb Vasc Biol, 20, pp. 2441-2447; \n\nLeviev, I., James, R.W., Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations (2000) Arterioscler Thromb Vasc Biol, 20, pp. 516-521; \n\nLeviev, I., Negro, F., James, R.W., Two alleles of the human paraoxonase gene produce different amounts of mRNA: An explanation for differences in serum concentrations of paraoxonase associated with the (Leu-Met 54) polymorphism (1997) Arterioscler Thomb Vasc Biol, 17, pp. 2935-2939; \n\nLi, W.F., Costa, L.G., Richter, R.J., Hagen, T., Shih, D.M., Tward, A., Lusis, A.J., Furlong, C.E., Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds (2000) Pharmacogenetics, 10, pp. 767-779; \n\nMackness, M.I., Arrol, S., Durrington, P.N., Paraoxonase prevents accumulation of lipidperoxide in low-density lipoprotein (1991) FEBS Lett, 286, pp. 152-154; \n\nMackness, M.I., Harty, D., Bhatnagar, D., Winocour, P.H., Arrol, S., Ishola, M., Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus (1991) Atherosclerosis, 86, pp. 193-199; \n\nMackness, M.I., Arrol, S., Abbott, C.A., Durrington, P.N., Protection of low density lipoprotein against oxidative modification by high density lipoprotein associated paraoxonase (1993) Atherosclerosis, 104, pp. 129-135; \n\nMackness, B., Mackness, M.I., Arrol, S., Turkie, W., Durrington, P.N., Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon (1997) Br J Pharmacol, 122, pp. 265-268; \n\nMackness, M.I., Arrol, S., Mackness, B., Durrington, P.N., Alloenzymes of paraoxonase and effectiveness of high-density lipoprotein in protecting low-density lipoprotein against lipid peroxidation (1997) Lancet, 349, pp. 851-852; \n\nMackness, B., Mackness, M.I., Arrol, S., Turkie, W., Julier, K., Abuasha, B., Miller, J.E., Durrington, P.N., Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus (1998) Atherosclerosis, 139, pp. 341-349; \n\nMackness, B., Mackness, M.I., Arrol, S., Turkie, W., Durrington, P.N., Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high-density lipoprotein against low-density lipoprotein oxidative modification (1998) FEBS Lett, 423, pp. 57-60; \n\nMackness, B., Durrington, P.N., McElduff, P., Yarnell, J., Azam, N., Watt, M., Mackness, M.I., Low paraoxonase activity predicts coronary events in the Caerphilly prospective study (2003) Circulation, 107, pp. 2775-2779; \n\nOdawara, M., Tachi, Y., Yamashita, K., Paraoxonase polymorphism (Gln192Arg) is associated with coronary heart disease in Japanese noninsulin-dependent diabetes mellitus (1997) J Clin Endocrinol Metab, 82, pp. 2257-2260; \n\nOmbres, D., Pannitteri, G., Montali, A., Gandeloro, A., Seccareccia, F., Campagna, F., Cantini, R., Area, M., The Gln-Arg 192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in Italian patients (1998) Arterioscler Thromb Vasc Biol, 18, pp. 1611-1616; \n\nParagh, G., Seres, I., Balogh, Z., The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia (1998) Nephron, 80, pp. 166-170; \n\nParagh, G., Balagh, Z., Seres, I., Harangi, M., Boda, J., Kovacs, P., Effect of gemfibrozil on HDL-associated serum paraoxonase activity and lipoprotein profile in patients with hyperlipidaemia (2000) Clin Drug Invest, 19, pp. 277-282; \n\nRichter, R.J., Furlong, C.E., Determination of paraoxonase (PON1) status requires more than genotyping (1999) Pharmacogenetics, 9, pp. 745-753; \n\nRodrigo, L., Mackness, B., Durrington, P.N., Hernandez, A., Mackness, M.I., Hydrolysis of platelet-activating factor by human serum paraoxonase (2001) Biochemistry J, 354, pp. 1-7; \n\nSaha, N., Roy, A.C., Teo, S.H., Tay, J.S.H., Ratnam, S.S., Influence of serum paraoxonase polymorphism on serum lipids and lipoproteins (1991) Clin Genet, 40, pp. 277-282; \n\nSanghera, D.K., Saha, N., Aston, C.E., Kamboh, M.I., Genetic polymorphism of paraoxonase and the risk of coronary heart disease (1997) Arterioscler Thromb Vasc Biol, 17, pp. 1067-1073; \n\nSanghera, D.K., Saha, N., Kamboh, M.I., The codon 55 polymorphism in the paraoxonase 1 gene is not associated with the risk of coronary heart disease in Asian Indian and Chinese (1998) Atherosclerosis, 136, pp. 217-223; \n\nSerrato, M., Marian, A.J., A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease (1995) J Clin Invest, 96, pp. 3005-3008; \n\nSuehiro, T., Nakamura, T., Inoue, M., Shiinoki, T., Ikeda, Y., Kumon, Y., Shindo, M., Hashimoto, K., A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression (2000) Atherosclerosis, 150, pp. 295-298; \n\nSutherland, W.H.F., Walker, R.J., De Jong, S.A., Van Rij, A.M., Phillips, V., Walker, H.L., Reduced postprandial serum paraoxonase activity after a meal rich in used cooking fat (1999) Arterioscler Thomb Vasc Biol, 19, pp. 1340-1347; \n\nTomas, M., Senti, M., Elosua, R., Vila, J., Sala, J., Masia, R., Marrugat, J., Interaction between the Gln-Arg 192 variants of the paraoxonase gene and oleic acid intake as a determinant of high-density lipoprotein cholesterol and paraoxonase activity (2001) Eur J Pharmacol, 432, pp. 121-128; \n\nTomas, M., Elosua, R., Senti, M., Molina, L., Vila, J., Anglada, R., Fito, M., Marrugat, J., Paraoxonase1-192 polymorphism modulates the effects of regular and acute exercise on paraoxonase1 activity (2002) J Lipid Res, 43, pp. 713-720; \n\nWang, X., Fan, Z., Huang, J., Su, S., Yu, Q., Zhao, J., Hui, R., Gu, D., Extensive association analysis between polymorphisms of PON gene cluster with coronary heart disease in Chinese Han population (2003) Arterioscler Thromb Vasc Biol, 23, pp. 328-334; \n\nWatson, A.D., Berliner, J.A., Hama, S.Y., La Du, B.N., Faull, K.F., Fogelman, A.M., Protective effect of high density lipoprotein associated paraoxonase: Inhibition of the biological activity of minimally oxidised low density lipoprotein (1995) J Clin Invest, 96, pp. 2882-2891; \n\nWheeler, J.G., Keavney, B.D., Watkins, H., Collins, R., Danesh, J., Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: Meta-analysis of 43 studies (2004) Lancet, 363, pp. 689-695; \n\nZama, T., Murata, M., Matsubara, Y., Kawano, K., Aoki, N., Yoshino, H., Watanabe, G., Ikeda, Y., A 192 Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese (1997) Arterioscler Thromb Vasc Biol, 17, pp. 3565-3569", "hasCitationDuplums" : false, "userChangeableUntil" : "2016-02-21T15:57:34.000+0000", "publishDate" : "2015-11-23T15:57:34.000+0000", "directInstitutesForSort" : "", "ownerAuthorCount" : 9, "ownerInstituteCount" : 8, "directInstituteCount" : 0, "authorCount" : 5, "contributorCount" : 0, "hasQualityFactor" : true, "link" : "/api/publication/25176443", "label" : "Phuntuwate W et al. Paraoxonase 1 status in the Thai population. (2005) JOURNAL OF HUMAN GENETICS 1434-5161 1435-232X 50 6 293-300", "template" : "